[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

[IP] MiniMed Inc. Introduces Next Generation Insulin Infusion Pump

Found the following on Quicken.com ticker tracker

MiniMed Inc. Introduces Next Generation Insulin Infusion Pump for Diabetes; 
New Model 508 Offers New Features for Diabetes Patients

SYLMAR, California--(BUSINESS WIRE)--October 4, 1999--MiniMed Inc. (Nasdaq: 
<A HREF="aol://4785:MNMD">MNMD</A>) today announced the introduction of its 
latest model insulin infusion pump for the treatment of diabetes, the Model 
508. The Model 508 offers several new features, including remote programming 
capabilities to administer or suspend insulin delivery, and the capability to 
program multiple patient-specific delivery patterns. The Model 508 also 
includes a low volume alert, an optional vibrate mode, and a child block 
feature to restrict programming. The Model 508 received 510(k) clearance by 
the Federal Food and Drug Administration in June 1999, and will bear the CE 
mark, enabling the product to be marketed throughout both the United States 
and the European Union. 

Commenting on this new product, Alfred E. Mann, Chairman of the Board and 
Chief Executive Officer, stated, "The introduction of the Model 508 
illustrates MiniMed's continuing commitment to its customers by adding 
important new features. Especially of interest is the remote programming 
capability of the Model 508 which enables customers to conveniently and 
discretely program bolus insulin delivery without accessing the pump by using 
radio frequency telemetry with a small, hand-held programmer. This new model 
also includes several new safety features, such as a low volume alert which 
notifies patients when reservoir levels are low, and a child block to provide 
added assurance to parents with young children who are using insulin pump 
therapy to treat their disease." 

Terrance H. Gregg, President and Chief Operating Officer, added, "The Model 
508 has additional flexible programming capabilities to accommodate 
individual lifestyle patterns, and enables customers to program and store up 
to three different basal rates of insulin delivery. This is particularly 
important to patients whose insulin needs vary due to schedule changes or 
lifestyle needs. Like its predecessor, the 507C, the Model 508 will store 90 
days worth of data which may be downloaded to a personal computer to help 
physicians review their patients' insulin requirements for improved 
management of diabetes. We are also pleased to introduce our new disposable 
infusion set, the Sof-set Micro QR, for use with all of our external infusion 
delivery systems, including the Model 508. The Sof-set Micro QR received FDA 
clearance on September 3, 1999 and is designed to improve patient comfort by 
reducing the cannula length by one-third." 

MiniMed Inc. designs, develops, manufactures and markets advanced infusion 
systems with a primary emphasis on the intensive management of diabetes. The 
Company's products include external pumps and related disposables, a 
continuous glucose monitoring system product and the distribution of an 
implantable insulin pump, which is currently approved for sale in the 
European Community and has not yet been cleared for marketing in the U.S. The 
Company also distributes other diabetes supplies and pharmaceutical products. 

for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml